logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Postoperative Nausea And Vomiting

    FiltersReset Filters
    26 results

    • aponvie

      (APREPITANT)
      Heron Therapeutics, Inc.
      Usage: APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. It has not been studied for treating established nausea and vomiting.

    • barhemsys

      (Amisulpride)
      Acacia Pharma Ltd
      Usage: BARHEMSYS® is indicated for adults to prevent and treat postoperative nausea and vomiting (PONV), either alone or in combination with a different class antiemetic, and for patients who have or have not received prior antiemetic prophylaxis.

    • chlorpromazine hydrochloride

      (Chlorpromazine hydrochloride)
      Devatis, Inc.
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, relieving pre-surgery anxiety, managing acute intermittent porphyria, adjunctive treatment of tetanus, addressing manic episodes, and treating severe behavioral issues in children, including hyperactivity and conduct disorders.

    • chlorpromazine hydrochloride

      (Chlorpromazine Hydrochloride)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, and treating acute intermittent porphyria. It also aids in tetanus treatment, addresses manic-depressive illness, relieves intractable hiccups, and treats severe behavioral issues in children aged 1 to 12.

    • fosaprepitant

      (Fosaprepitant)
      MSN LABORATORIES PRIVATE LIMITED
      Usage: Fosaprepitant for injection is indicated for the prevention of acute and delayed nausea and vomiting in adults and pediatric patients (6 months and older) undergoing highly and moderately emetogenic cancer chemotherapy. It is not studied for treating established nausea and vomiting.

    • granisetron hydrochloride

      (Granisetron Hydrochloride)
      Breckenridge Pharmaceutical, Inc.
      Usage: Granisetron hydrochloride tablets are indicated for preventing nausea and vomiting related to emetogenic cancer therapy (including high-dose cisplatin) and radiation treatments, such as total body irradiation and fractionated abdominal radiation.

    • ondansetron

      (ondansetron hydrochloride)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Ondansetron is indicated for preventing nausea and vomiting caused by highly and moderately emetogenic cancer chemotherapy, specific radiotherapy treatments, and postoperative settings.

    • ondansetron

      (Ondansetron Hydrochloride)
      Eugia US LLC
      Usage: Ondansetron Injection is indicated for preventing nausea and vomiting related to emetogenic cancer chemotherapy (for patients aged 6 months and older) and preventing postoperative nausea and vomiting (for patients aged 1 month and older), particularly when avoiding these conditions is critical.

    • ondansetron

      (ONDANSETRON)
      Hospira, Inc.
      Usage: Ondansetron Injection is indicated for preventing nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy and for preventing postoperative nausea and vomiting in patients aged 1 month and older. Routine prophylaxis is not recommended in patients with low risk for nausea/vomiting post-surgery.

    • ondansetron

      (Ondansetron)
      Aurobindo Pharma Limited
      Usage: Ondansetron orally disintegrating tablets are indicated for preventing nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy, specific radiotherapy regimens, and postoperative nausea and vomiting.